What to expect when you take Pseudoephedrine hydrochloride and Hydroxyzine?

Do you take Pseudoephedrine hydrochloride and Hydroxyzine? Find out below what new side effects and undetected conditions you may have in 1 to 5 years. This forecast is created after we perform predictive analysis on healthcare big data, including data collected from FDA. It will be updated regularly.

To personalized this forecast to you, click here.




Female

Females aged 20:

Within 1 year:

  • n/a
back to top

Within 2 years:

  • n/a
back to top

Within 3 years:

  • n/a
back to top

Within 4 years:

  • n/a
back to top

Within 5 years:

  • n/a
back to top

Females aged 40:

Within 1 year:

Most common symptoms:

  1. Itching (25%)
  2. Anorexia (17%)
  3. Nausea (17%)
  4. Tachyphrenia (17%)
  5. Drug Ineffective (17%)
  6. Cough (17%)
  7. Pancreatitis (17%)
  8. Nasopharyngitis (17%)
  9. Dyspnea (8%)
  10. Dehydration (8%)

Fastest developing symptoms:

  • n/a

Other co-existing conditions:

  1. Depression (58%)
  2. High Blood Cholesterol (33%)
  3. Gastroesophageal Reflux Disease (33%)
  4. Bipolar Disorder (25%)
  5. Constipation (17%)
  6. Muscle Spasms (17%)
  7. Gastric Disorder (17%)
  8. Migraine (17%)
  9. Tremor (17%)
  10. Itching (8%)
back to top

Within 2 years:

Most common symptoms:

  1. Itching (27%)
  2. Anorexia (18%)
  3. Cough (18%)
  4. Pancreatitis (18%)
  5. Nausea (18%)
  6. Nasopharyngitis (18%)
  7. Tachyphrenia (18%)
  8. Dehydration (9%)
  9. Apnea (9%)
  10. Burning Sensation (9%)

Fastest developing symptoms:

  1. Weight Decreased (9%)
  2. Headache (9%)
  3. Disturbance In Attention (9%)
  4. Confusional State (9%)
  5. Blood Pressure Fluctuation (9%)

Other co-existing conditions:

  1. Depression (55%)
  2. High Blood Cholesterol (36%)
  3. Bipolar Disorder (27%)
  4. Gastroesophageal Reflux Disease (27%)
  5. Tremor (18%)
  6. Gastric Disorder (18%)
  7. Migraine (18%)
  8. Weight Loss (9%)
  9. Hypovitaminosis (9%)
  10. Asthma (9%)
back to top

Within 3 years:

Most common symptoms:

  1. Itching (25%)
  2. Anorexia (17%)
  3. Cough (17%)
  4. Pancreatitis (17%)
  5. Nausea (17%)
  6. Nasopharyngitis (17%)
  7. Tachyphrenia (17%)
  8. Drug Ineffective (8%)
  9. Apnea (8%)
  10. Burning Sensation (8%)

Fastest developing symptoms:

  1. Weight Decreased (17%)
  2. Weight Loss (8%)
  3. Escherichia Infection (8%)
  4. Emphysema (8%)
  5. Emotional Disorder (8%)
  6. Disturbance In Attention (8%)
  7. Diabetes Mellitus Inadequate Control (8%)
  8. Depression (8%)
  9. Coronary Heart Disease (8%)
  10. Coronary Artery Restenosis (8%)

Other co-existing conditions:

  1. Depression (50%)
  2. High Blood Cholesterol (33%)
  3. Bipolar Disorder (25%)
  4. Gastroesophageal Reflux Disease (25%)
  5. Tremor (17%)
  6. Gastric Disorder (17%)
  7. Migraine (17%)
  8. Weight Loss (8%)
  9. Hypersensitivity (8%)
  10. Asthma (8%)
back to top

Within 4 years:

Most common symptoms:

  1. Drug Ineffective (29%)
  2. Itching (21%)
  3. Anorexia (14%)
  4. Skin Ulcer (14%)
  5. Nausea (14%)
  6. Apnea (7%)
  7. Cardio-Respiratory Arrest (7%)
  8. Creatine Urine Decreased (7%)
  9. Creatinine Renal Clearance Decreased (7%)
  10. Dehydration (7%)

Fastest developing symptoms:

  1. Suicide Attempt (21%)
  2. Weight Decreased (14%)
  3. Overdose (14%)
  4. Weight Loss (7%)
  5. Depression (7%)
  6. Colon Adenoma (7%)
  7. Confusional State (7%)
  8. Coronary Artery Restenosis (7%)
  9. Coronary Heart Disease (7%)
  10. Diabetes Mellitus Inadequate Control (7%)

Other co-existing conditions:

  1. Itching (29%)
  2. Bipolar Disorder (29%)
  3. Migraine (21%)
  4. Pain (14%)
  5. Sleep Disorder (14%)
  6. Depression (14%)
  7. Hypersensitivity (7%)
  8. Gastroesophageal Reflux Disease (7%)
  9. Faeces Hard (7%)
  10. Dyspnea (7%)
back to top

Within 5 years:

Most common symptoms:

  1. Drug Ineffective (29%)
  2. Itching (21%)
  3. Anorexia (14%)
  4. Skin Ulcer (14%)
  5. Nausea (14%)
  6. Apnea (7%)
  7. Cardio-Respiratory Arrest (7%)
  8. Creatine Urine Decreased (7%)
  9. Creatinine Renal Clearance Decreased (7%)
  10. Dehydration (7%)

Fastest developing symptoms:

  1. Suicide Attempt (21%)
  2. Weight Decreased (14%)
  3. Overdose (14%)
  4. Weight Loss (7%)
  5. Depression (7%)
  6. Colon Adenoma (7%)
  7. Confusional State (7%)
  8. Coronary Artery Restenosis (7%)
  9. Coronary Heart Disease (7%)
  10. Diabetes Mellitus Inadequate Control (7%)

Other co-existing conditions:

  1. Itching (29%)
  2. Bipolar Disorder (29%)
  3. Migraine (21%)
  4. Pain (14%)
  5. Sleep Disorder (14%)
  6. Depression (14%)
  7. Hypersensitivity (7%)
  8. Gastroesophageal Reflux Disease (7%)
  9. Faeces Hard (7%)
  10. Dyspnea (7%)
back to top

Females aged 60:

Within 1 year:

Most common symptoms:

  1. Anaphylaxis (21%)
  2. Fatigue (21%)
  3. Itching (21%)
  4. Urinary Incontinence (14%)
  5. Multiple Allergies (14%)
  6. Alanine Aminotransferase Increased (14%)
  7. Arthritis (14%)
  8. Aspartate Aminotransferase Increased (14%)
  9. Atrial Fibrillation/flutter (14%)
  10. Bipolar I Disorder (14%)

Fastest developing symptoms:

  1. Abnormal Dreams (21%)
  2. Agitation (21%)
  3. Anger (21%)
  4. Mood Swings (21%)
  5. Frustration (21%)
  6. Dyspnea (14%)
  7. Weakness (7%)
  8. Dyspnea Exertional (7%)
  9. Abdominal Pain (7%)
  10. Abdominal Pain Upper (7%)

Other co-existing conditions:

  1. High Blood Cholesterol (36%)
  2. Asthma (29%)
  3. Hypersensitivity (29%)
  4. Gastrointestinal Disorder (21%)
  5. Thyroid Diseases (21%)
  6. Sleep Disorder (21%)
  7. Arthritis (21%)
  8. Quit Smoking (21%)
  9. Back Disorder (21%)
  10. Pain (21%)
back to top

Within 2 years:

Most common symptoms:

  1. Fatigue (29%)
  2. Anaphylaxis (21%)
  3. Itching (21%)
  4. Urinary Incontinence (14%)
  5. Hypothyroidism (14%)
  6. Alanine Aminotransferase Increased (14%)
  7. Arthritis (14%)
  8. Aspartate Aminotransferase Increased (14%)
  9. Atrial Fibrillation/flutter (14%)
  10. Bipolar I Disorder (14%)

Fastest developing symptoms:

  1. Anger (21%)
  2. Frustration (21%)
  3. Mood Swings (21%)
  4. Abnormal Dreams (21%)
  5. Agitation (21%)
  6. Pressure Ulcer (14%)
  7. Dyspnea (14%)
  8. Fever (7%)
  9. Failure To Thrive (7%)
  10. Enlarged Heart (7%)

Other co-existing conditions:

  1. High Blood Cholesterol (29%)
  2. Hypersensitivity (29%)
  3. Asthma (29%)
  4. Gastrointestinal Disorder (21%)
  5. Pain (21%)
  6. Itching (21%)
  7. Dementia Alzheimer's Type (21%)
  8. Thyroid Diseases (21%)
  9. Back Disorder (21%)
  10. Arthritis (21%)
back to top

Within 3 years:

Most common symptoms:

  1. Fatigue (36%)
  2. Itching (27%)
  3. Urinary Incontinence (18%)
  4. Alanine Aminotransferase Increased (18%)
  5. Arthritis (18%)
  6. Aspartate Aminotransferase Increased (18%)
  7. Atrial Fibrillation/flutter (18%)
  8. Bipolar I Disorder (18%)
  9. Blood Alkaline Phosphatase Increased (18%)
  10. Blood Bilirubin Increased (18%)

Fastest developing symptoms:

  1. Anger (27%)
  2. Frustration (27%)
  3. Mood Swings (27%)
  4. Abnormal Dreams (27%)
  5. Agitation (27%)
  6. Pressure Ulcer (18%)
  7. Dyspnea (18%)
  8. Fever (9%)
  9. Failure To Thrive (9%)
  10. Enlarged Heart (9%)

Other co-existing conditions:

  1. High Blood Cholesterol (36%)
  2. Hypersensitivity (36%)
  3. Asthma (36%)
  4. Gastrointestinal Disorder (27%)
  5. Pain (27%)
  6. Itching (27%)
  7. Dementia Alzheimer's Type (27%)
  8. Thyroid Diseases (27%)
  9. Back Disorder (27%)
  10. Arthritis (27%)
back to top

Within 4 years:

Most common symptoms:

  1. Fatigue (36%)
  2. Itching (27%)
  3. Urinary Incontinence (18%)
  4. Alanine Aminotransferase Increased (18%)
  5. Arthritis (18%)
  6. Aspartate Aminotransferase Increased (18%)
  7. Atrial Fibrillation/flutter (18%)
  8. Bipolar I Disorder (18%)
  9. Blood Alkaline Phosphatase Increased (18%)
  10. Blood Bilirubin Increased (18%)

Fastest developing symptoms:

  1. Anger (27%)
  2. Frustration (27%)
  3. Mood Swings (27%)
  4. Abnormal Dreams (27%)
  5. Agitation (27%)
  6. Pressure Ulcer (18%)
  7. Dyspnea (18%)
  8. Fever (9%)
  9. Failure To Thrive (9%)
  10. Enlarged Heart (9%)

Other co-existing conditions:

  1. High Blood Cholesterol (36%)
  2. Hypersensitivity (36%)
  3. Asthma (36%)
  4. Gastrointestinal Disorder (27%)
  5. Pain (27%)
  6. Itching (27%)
  7. Dementia Alzheimer's Type (27%)
  8. Thyroid Diseases (27%)
  9. Back Disorder (27%)
  10. Arthritis (27%)
back to top

Within 5 years:

Most common symptoms:

  1. Fatigue (33%)
  2. Itching (25%)
  3. Urinary Incontinence (17%)
  4. Hypothyroidism (17%)
  5. Alanine Aminotransferase Increased (17%)
  6. Arthritis (17%)
  7. Aspartate Aminotransferase Increased (17%)
  8. Atrial Fibrillation/flutter (17%)
  9. Bipolar I Disorder (17%)
  10. Blood Alkaline Phosphatase Increased (17%)

Fastest developing symptoms:

  1. Frustration (25%)
  2. Abnormal Dreams (25%)
  3. Agitation (25%)
  4. Anger (25%)
  5. Mood Swings (25%)
  6. Pressure Ulcer (17%)
  7. Dyspnea (17%)
  8. Double Outlet Right Ventricle (8%)
  9. Cuts And Puncture Wounds (8%)
  10. Dacryostenosis Acquired (8%)

Other co-existing conditions:

  1. High Blood Cholesterol (33%)
  2. Hypersensitivity (33%)
  3. Asthma (33%)
  4. Arthritis (25%)
  5. Sleep Disorder (25%)
  6. Quit Smoking (25%)
  7. Back Disorder (25%)
  8. Dementia Alzheimer's Type (25%)
  9. Gastrointestinal Disorder (25%)
  10. Thyroid Diseases (25%)
back to top

Male

Males aged 20:

Within 1 year:

  • n/a
back to top

Within 2 years:

  • n/a
back to top

Within 3 years:

  • n/a
back to top

Within 4 years:

  • n/a
back to top

Within 5 years:

  • n/a
back to top

Males aged 40:

Within 1 year:

  • n/a
back to top

Within 2 years:

  • n/a
back to top

Within 3 years:

  • n/a
back to top

Within 4 years:

  • n/a
back to top

Within 5 years:

  • n/a
back to top

Males aged 60:

Within 1 year:

  • n/a
back to top

Within 2 years:

  • n/a
back to top

Within 3 years:

  • n/a
back to top

Within 4 years:

  • n/a
back to top

Within 5 years:

  • n/a
back to top

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.